Your browser doesn't support javascript.
loading
Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254.
Thanarajasingam, Gita; Atherton, Pamela J; Novotny, Paul J; Loprinzi, Charles L; Sloan, Jeff A; Grothey, Axel.
Affiliation
  • Thanarajasingam G; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Electronic address: thanarajasingam.gita@mayo.edu.
  • Atherton PJ; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Novotny PJ; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Loprinzi CL; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
  • Sloan JA; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Grothey A; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
Lancet Oncol ; 17(5): 663-70, 2016 05.
Article in En | MEDLINE | ID: mdl-27083333

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Adverse Drug Reaction Reporting Systems / Long Term Adverse Effects Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Lancet Oncol Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Adverse Drug Reaction Reporting Systems / Long Term Adverse Effects Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Lancet Oncol Year: 2016 Type: Article